Log in to search using one of your social media accounts:

 

Medical News Today: Multiple sclerosis: Skin cells may help to repair nerve damage
Researchers could be on the verge of a new treatment for multiple sclerosis; they reveal how transplanting neural stem cells derived from a patient's own skin could help to repair nerve damage caused by the disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 23, 2018 Category: Consumer Health News Tags: Multiple Sclerosis Source Type: news

Stigma increases risk of depression for people with Multiple Sclerosis
(Penn State) People with Multiple Sclerosis -- MS -- who feel stigmatized are more likely to suffer from depression, according to researchers, who add that having a support system of friends and family and a sense of autonomy may help reduce the harmful effects of stigma. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 20, 2018 Category: International Medicine & Public Health Source Type: news

Technologies for advanced gait and balance assessments in people with multiple sclerosis - Shanahan CJ, Boonstra FMC, Cofr é Lizama LE, Strik M, Moffat BA, Khan F, Kilpatrick TJ, van der Walt A, Galea MP, Kolbe SC.
Subtle gait and balance dysfunction is a precursor to loss of mobility in multiple sclerosis (MS). Biomechanical assessments using advanced gait and balance analysis technologies can identify these subtle changes and could be used to predict mobility loss ... (Source: SafetyLit)
Source: SafetyLit - February 19, 2018 Category: International Medicine & Public Health Tags: Falls Source Type: news

FDA Clears Higher-Dose Glatopa Generic for MS FDA Clears Higher-Dose Glatopa Generic for MS
Glatopa 40 mg/mL joins already-approved Glatopa 20 mg/mL, a glatiramer acetate generic for treatment of relapsing forms of multiple sclerosis.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 15, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news

DIY faecal transplants carry risks including HIV and hepatitis, warn experts
Faecal transplants have been used in medical settings to tackle superbugs, but following YouTube videos at home is too risky, say researchersConcerns have been raised about the growing trend for DIY faecal transplants, with experts fearing such attempts could put individuals at an increased risk of HIV and hepatitis as well as conditions ranging from Parkinson ’s and multiple sclerosis to obesity and sleep disorders.Thetransfer of faeces from one human to another has gained attention as a growing number of studies have suggested links between microbes in the gut anda host of health problems, from autoimmune diseases ...
Source: Guardian Unlimited Science - February 15, 2018 Category: Science Authors: Nicola Davis in Austin Tags: Microbiology Human biology Infectious diseases Medical research Science Health Source Type: news

Eye and balance exercises may ease multiple sclerosis symptoms
Reuters Health - People with multiple sclerosis who do balance and eye movement exercises may feel steadier on their feet and experience less fatigue and dizziness, a small trial suggests. (Source: Reuters: Health)
Source: Reuters: Health - February 15, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Why Rock Climbing May Be the Ultimate Full-Body Workout
The muscles in your hips and torso strain to hold your lower half against the wall. You arch backward and extend one hand up to clasp the next hold—your thighs and calves burning with the effort of holding you steady and in balance. A moment later, when the tips of your fingers have secured their grip, there’s a wholesale shift in the muscles you call on to maintain your safe purchase on the climbing wall. Exercise is all about engaging your muscles—from your heart to your biceps and quads—and asking those muscles to perform work. And when it comes to activating and training a diverse range of muscl...
Source: TIME: Health - February 15, 2018 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Exercise/Fitness healthytime Source Type: news

Rituximab: More Effective Than Other Initial MS Treatments? Rituximab: More Effective Than Other Initial MS Treatments?
A Swedish database analysis shows that rituximab excels in newly diagnosed relapsing-remitting multiple sclerosis. Dr Laurie Barclay takes a closer look.Medscape Neurology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 14, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Viewpoint Source Type: news

Sandoz wins FDA nod for generic, injectable MS drug
Sandoz said today that the FDA has approved its Glatopa glatiramer acetate injection as a generic version of Copaxone to treat relapsing forms of multiple sclerosis. The therapy, which is given three days per week, is administered using the Glatopaject injection device. Get the full story at our sister site, Drug Delivery Business News. The post Sandoz wins FDA nod for generic, injectable MS drug appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 13, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance Wall Street Beat Novartis sandoz Source Type: news

Teva planned for second generic Copaxone to enter market in 2018
TEL AVIV (Reuters) - Israel-based Teva Pharmaceutical Industries said on Tuesday it had anticipated and planned for a second generic competitor to its multiple sclerosis treatment Copaxone to enter the market in 2018. (Source: Reuters: Health)
Source: Reuters: Health - February 13, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Sandoz announces US FDA approval and launch of Glatopa(R) 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis
Glatopa® 40 mg/mL is a fully substitutable, AP-rated generic version of Copaxone®* (glatiramer acetate injection) 40 mg/mL Glatopa 40 mg/mL, along with Glatopa® 20 mg/mL, which was launched in the US in June 2015, will offer patients a compl... Biopharmaceuticals, Generics, FDA, Product Launch Sandoz, Novartis, Glatopa, glatiramer, Copaxone, multiple sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 13, 2018 Category: Pharmaceuticals Source Type: news

Novartis gains U.S. approval for delayed MS drug
ZURICH (Reuters) - Novartis's Sandoz division has won U.S. approval for a larger dosage of its Glatopa drug for multiple sclerosis (MS) patients, ending a costly delay that allowed rival generics makers to beat it to market. (Source: Reuters: Health)
Source: Reuters: Health - February 13, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Novartis gets U.S. approval for bigger dose Glatopa MS treatment
ZURICH (Reuters) - Novartis's Sandoz division said on Tuesday it has won approval in the United States for a larger dosage of its Glatopa treatment for multiple sclerosis patients. (Source: Reuters: Health)
Source: Reuters: Health - February 13, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Medical cannabis significantly safer for elderly with chronic pain than Opioids
(American Associates, Ben-Gurion University of the Negev) The new study, published in The European Journal of Internal Medicine, found cannabis therapy is safe and efficacious for elderly patients who are seeking to address cancer symptoms, Parkinson's disease, post-traumatic stress disorder, ulcerative colitis, Crohn's disease, multiple sclerosis, and other medical issues. After six months, more than 18 percent of patients surveyed had stopped using opioid analgesics or had reduced their dosage. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 13, 2018 Category: International Medicine & Public Health Source Type: news

Digital Cognitive Testing Uncovers Hidden Impairment in MS Digital Cognitive Testing Uncovers Hidden Impairment in MS
A computerized neuropsychological screen is taking the'guesswork'out of documenting disease impact and progression on cognitive outcomes in patients with multiple sclerosis, researchers say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 9, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

MS Drug Tysabri (Natalizumab) Poses Hard Choices for Women Wanting Children
THURSDAY, Feb. 8, 2018 -- A powerful multiple sclerosis drug presents women with a tough dilemma if they would like to have children, a pair of new studies suggests. Those who take Tysabri (natalizumab) to manage their MS are more likely to suffer... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 8, 2018 Category: General Medicine Source Type: news

Medical News Today: Brain-repairing protein may lead to new MS drugs
The mechanism set in motion by a protein implicated in the repair of myelin damage could hold the key to a better treatment for multiple sclerosis. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 7, 2018 Category: Consumer Health News Tags: Multiple Sclerosis Source Type: news

Biogen stops testing Tysabri to treat stroke after study fails
(Reuters) - Biogen Inc said on Wednesday it would stop developing its multiple sclerosis drug Tysabri to treat patients with acute ischemic stroke after it failed a mid-stage study. (Source: Reuters: Health)
Source: Reuters: Health - February 7, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Deep brain stimulation -- A new treatment approach in patients with multiple sclerosis
(Charit é - Universit ä tsmedizin Berlin) A pilot study conducted by researchers from Charit é 's NeuroCure Cluster of Excellence has shown that treatment with deep transcranial magnetic stimulation (dTMS) significantly reduces symptoms of fatigue in patients with multiple sclerosis (MS). Published in the current issue of the journal Neurology: Neuroimmunology& Neuroinflammation*, results from this research suggest that TMS is a safe option for the treatment of patients with MS. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 7, 2018 Category: International Medicine & Public Health Source Type: news

An intervention to improve balance in persons with multiple sclerosis - Bennett S, Leavitt VM.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - February 5, 2018 Category: International Medicine & Public Health Tags: Falls Source Type: news

Gold Nanocrystals May Remyelinate Lesions in Multiple Sclerosis Gold Nanocrystals May Remyelinate Lesions in Multiple Sclerosis
Animals treated with CNM-Au8 had improved motor function, a new study shows. Already shown safe in phase 1 trials, research with this'new therapeutic paradigm'will soon move to phase 2, researchers say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 5, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Extending dosing intervals reduces deadly side effect risk from multiple sclerosis drug
(NYU Langone Health / NYU School of Medicine) A commonly-prescribed multiple sclerosis (MS) infusion medication, natalizumab, linked to a rare but serious side effect is safer to use when dosing intervals are extended, according to a new study led by MS specialists at NYU Langone Health. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 2, 2018 Category: International Medicine & Public Health Source Type: news

Roche reports good results in 2017
Commenting on the Group ’s results, Roche CEO Severin Schwan said: “In 2017, we made significant progress with good growth in both divisions driven by newly launched medicines and tests. I am particularly pleased with the successful launch of Ocrevus and Hemlibra and important approvals for additional indications for P erjeta, Tecentriq and Alecensa. These medicines bring substantial benefit to patients with serious diseases such as multiple sclerosis, cancer and haemophilia. Based on our strong product portfolio we are well positioned for the future.” (Source: Roche Media News)
Source: Roche Media News - February 1, 2018 Category: Pharmaceuticals Source Type: news

Roche reports good results in 2017
Commenting on the Group ’s results, Roche CEO Severin Schwan said: “In 2017, we made significant progress with good growth in both divisions driven by newly launched medicines and tests. I am particularly pleased with the successful launch of Ocrevus and Hemlibra and important approvals for additional indications for P erjeta, Tecentriq and Alecensa. These medicines bring substantial benefit to patients with serious diseases such as multiple sclerosis, cancer and haemophilia. Based on our strong product portfolio we are well positioned for the future.” (Source: Roche Investor Update)
Source: Roche Investor Update - February 1, 2018 Category: Pharmaceuticals Source Type: news

MS Patients May Gain From Balance-Focused Workouts
The new regimen -- called Balance and Eye-Movement Exercises for Persons with Multiple Sclerosis (BEEMS) -- had individuals perform balance and eye-movement exercises. (Source: WebMD Health)
Source: WebMD Health - January 31, 2018 Category: Consumer Health News Source Type: news

MS Patients May Gain From Balance-Focused Workouts
WEDNESDAY, Jan. 31, 2018 -- Problems with balance are a common hallmark of multiple sclerosis, but new research suggests a specially designed exercise program can help put patients on firmer ground. People with MS who enrolled in the 14-week... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 31, 2018 Category: General Medicine Source Type: news

Medical News Today: Multiple sclerosis: 'Guardian molecule' may lead to new treatment
A study of male mice finds that testosterone triggers production of a protective molecule that prevents the development of immune cells that attack myelin. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 30, 2018 Category: Consumer Health News Tags: Multiple Sclerosis Source Type: news

ACTRIMS 2018: Emerging Pathways, New Therapeutic Targets in MS ACTRIMS 2018: Emerging Pathways, New Therapeutic Targets in MS
A'powerhouse'lineup of speakers will be featured at the upcoming Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2018.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 29, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

CMSC Annual Meeting presents latest advances in multiple sclerosis diagnosis and treatment
(Consortium of MS Centers) The CMSC Annual Meeting, taking place May 30-June 2, 2018, at the Music City Center in Nashville, TN, serves as the largest educational conference and professional development event for healthcare clinicians, researchers, scientists and professionals in training engaged in the multiple sclerosis field. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 25, 2018 Category: International Medicine & Public Health Source Type: news

You Asked: Why Do Certain Songs Get Stuck in Your Head?
You can’t walk into the office without Rihanna’s voice singing “work work work work work work” in your head. And that one line from Lady Gaga’s “Bad Romance” still makes you want to scream. These are commonly known as earworm songs—those sticky tunes that continue to play in your head long after you wish you could skip to the next track. Experts call them “involuntary musical imagery.” And more than 90% of adults report hearing them on a weekly (if not daily) basis, finds a recent study in the journal Psychology of Music. While there’s a huge amount of perso...
Source: TIME: Health - January 24, 2018 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized earworm earworm definition earworm meaning earworm music earworm song earworm songs healthytime Research song stuck in head song stuck in my head what is an earworm why do songs get stuck in your head Source Type: news

Jefferson, Magee complete merger
Jefferson Health added its fourth new member since 2015 with the completion of its merger with Magee Rehabilitation Hospital.   The leaders of Jefferson and Magee said Tuesday the integration will enable two organizations, both nationally ranked, to provide “an even higher level of care” to patients regaining independence from spinal cord injury, stroke, brain injury, amputation, multiple sclerosis and/or orthopedic injuries. Jefferson and Magee have had a clinical affiliation for several decades.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 23, 2018 Category: Biotechnology Authors: John George Source Type: news

The relationship between gait variability and cognitive functions differs between fallers and non-fallers in MS - Kalron A, Aloni R, Dolev M, Frid L, Givon U, Menascu S.
The objective of the study was to determine if cognitive function is associated with step time variability in people with multiple sclerosis (PwMS). The study included 355 PwMS (218 women), average age 41.1 (SD  = 13.5), disease duration 5.9 (SD = 7.3) ... (Source: SafetyLit)
Source: SafetyLit - January 22, 2018 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

6,000-year-old track record for healing leaky gut
When I was traveling in India, I had the privilege of studying Ayurvedic medicine with traditional Master Healers. Surrounded by lakes, oceans and mountains, Kerala, India, is the birthplace of Ayurveda medicine. My plane landed in Mumbai. From there, I made the 800-mile trip to Kerala down on the southwestern-most tip of the Indian peninsula. With origins dating back 6,000 years, Kerala is the birthplace of Ayurvedic medicine. I spent a lot of time at the AyurMana or “ancient healing house.” This is the oldest existing school of Ayurvedic medicine in the world. It was there that I observed how quickly...
Source: Al Sears, MD Natural Remedies - January 17, 2018 Category: Complementary Medicine Authors: Cathy Card Tags: Health Natural Cures anxiety arthritis Cancer celiac disease chronic fatigue depression diabetes digestive issues fibromyalgia leaky gut multiple sclerosis schizophrenia Source Type: news

Depression and fatigue in multiple sclerosis: relation to exposure to violence and cerebrospinal fluid immunomarkers - Brenner P, Granqvist M, K önigsson J, Al Nimer F, Piehl F, Jokinen J.
Multiple sclerosis (MS) is a neuroinflammatory condition characterized by chronic dysregulation of immune responses leading to repeated episodes of inflammation in the central nervous system. Depression and fatigue are common among MS patients, even in ear... (Source: SafetyLit)
Source: SafetyLit - January 16, 2018 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Your NEJM Group Today: MS Review / HIV PrEP for Women / Texas Medical Director Opportunity
Here's what we selected for you today: NEJM Clinical Practice Center: Review: A number of interventions to modify the course of multiple sclerosis have been... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 16, 2018 Category: Primary Care Source Type: news

FDA Denies Health Claim for Vitamin D to Prevent MS FDA Denies Health Claim for Vitamin D to Prevent MS
The FDA responded to a petition, saying that after reviewing the evidence, there is no basis for the claim that vitamin D can prevent multiple sclerosis in healthy people.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 15, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news

Effects of sport climbing on multiple sclerosis - Steimer J, Weissert R.
Multiple sclerosis (MS) is an autoimmune and neurodegenerative disease of the central nervous system (CNS) with different types of disease courses (relapsing-remitting, secondary-progressive, primary progressive) that leads to physical as well as mental di... (Source: SafetyLit)
Source: SafetyLit - January 15, 2018 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

MS Drug Ocrelizumab (Ocrevus) Approved in Europe MS Drug Ocrelizumab (Ocrevus) Approved in Europe
The European Commission clears the anti-CD20 monoclonal antibody for adults with relapsing multiple sclerosis and early primary progressive multiple sclerosis.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 12, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news

New PET radiotracer offers insight into multiple sclerosis
Combining PET scans with a novel radiotracer could help researchers track damage...Read more on AuntMinnie.comRelated Reading: Did PET scan confirm CTE in living NFL player? PET, EEG show treatment effectiveness in comatose patient PET links low serotonin levels to dementia SNMMI: PET helps track neuroinflammation in MS fMRI uncovers benefits of video games for MS patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 12, 2018 Category: Radiology Source Type: news

ICYMI: Why 2017 medicine approvals matter
This week, the U.S. Food and Drug Administration ’s (FDA) Center for Drug Evaluation and Research (CDER)released its 2017 New Drug Therapy Approvals report. Last year marked an extraordinary milestone for the biopharmaceutical industry and the FDA with major medicine approvals. According to the report, the FDAapproved 46 new molecular entities for a range of disease states -- the highest number of new medications in 21 years. (Source: The Catalyst)
Source: The Catalyst - January 12, 2018 Category: Pharmaceuticals Tags: FDA Drug Development Multiple Sclerosis PDUFA New Era of Medicine Source Type: news

Roche's star MS medicine Ocrevus wins EU approval
ZURICH (Reuters) - The European Union approved Roche's multiple sclerosis medicine Ocrevus, one the Swiss company's key new drugs that likely neared $1 billion in revenue in its first nine months on the U.S. market. (Source: Reuters: Health)
Source: Reuters: Health - January 12, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Roche ’s OCREVUS (ocrelizumab) approved in the European Union for relapsing forms of multiple sclerosis and primary progressive multiple sclerosis
Roche announced today that the European Commission (EC) has granted marketing authorisation for OCREVUS ® (ocrelizumab) for patients with active relapsing forms of multiple sclerosis defined by clinical or imaging features and for patients with early primary progressive multiple sclerosis in terms of disease duration and level of disability, and with imaging features characteristic of inflammatory ac tivity. (Source: Roche Media News)
Source: Roche Media News - January 12, 2018 Category: Pharmaceuticals Source Type: news

Roche ’s OCREVUS (ocrelizumab) approved in the European Union for relapsing forms of multiple sclerosis and primary progressive multiple sclerosis
Roche announced today that the European Commission (EC) has granted marketing authorisation for OCREVUS ® (ocrelizumab) for patients with active relapsing forms of multiple sclerosis defined by clinical or imaging features and for patients with early primary progressive multiple sclerosis in terms of disease duration and level of disability, and with imaging features characteristic of inflammatory ac tivity. (Source: Roche Investor Update)
Source: Roche Investor Update - January 12, 2018 Category: Pharmaceuticals Source Type: news

An innovative PET tracer can measure damage from multiple sclerosis in mouse models
(University of Chicago Medical Center) In the Jan. 12, 2018, Scientific Reports, a research team describes early tests of a minimally-invasive way to assess myelin damage -- the hallmark of multiple sclerosis -- using positron emission tomography (PET). This approach could be used to follow MS lesions over time. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 12, 2018 Category: International Medicine & Public Health Source Type: news

Dr. Helen Genova awarded grant for novel emotional processing study in multiple sclerosis
(Kessler Foundation) Helen Genova, Ph.D., Assistant Director of Neuropsychology& Neuroscience Research at Kessler Foundation, has been awarded a $44,000 grant from the National Multiple Sclerosis Society. The grant funds her research on emotional processing deficits in people with multiple sclerosis, an autoimmune degenerative disease of the central nervous system associated with significant behavioral and emotional sequelae. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 10, 2018 Category: International Medicine & Public Health Source Type: news

Effects of estrogen treatment combat multiple sclerosis in mice
FINDINGSA study by UCLA researchers reveals the cellular basis for how the hormone estrogen protects against damage to the central nervous system in women with multiple sclerosis, or MS. The researchers found that estrogen treatment exerts positive effects on two types of cells during disease — immune cells in the brain as well as cells called oligodendrocytes.BACKGROUNDUCLADr. Rhonda VoskuhlMultiple sclerosis is a chronic autoimmune, neurodegenerative disease marked by visual impairment, weakness and sensory loss, as well as cognitive decline. These symptoms emerge when inflammatory immune cells destroy the myelin s...
Source: UCLA Newsroom: Health Sciences - January 10, 2018 Category: Universities & Medical Training Source Type: news

Researchers find potential path to repair nerves damaged by multiple sclerosis
FINDINGSA UCLA study found that gene expression in specific cells and in specific regions of the body can provide a more precise, neuroprotective approach than traditional treatments for neurological diseases. Gene expression is the process by which genetic instructions are used to synthesize gene products, such as proteins, which go on to perform essential functions.For multiple sclerosis, specifically, increasing cholesterol synthesis gene expression in astrocytes of the spinal cord can be a pathway to repair nerves that affect walking.BACKGROUNDMultiple sclerosis is an autoimmune, neurodegenerative disease characterized...
Source: UCLA Newsroom: Health Sciences - January 9, 2018 Category: Universities & Medical Training Source Type: news

Multiple sclerosis: Cholesterol crystals prevent regeneration in central nervous system
(Technical University of Munich (TUM)) Multiple Sclerosis is a chronic inflammatory disease of the central nervous system, in which the immune cells attack myelin sheaths. Regeneration of myelin sheaths is necessary for patients to recover from MS relapses. Nevertheless, the ability to regenerate decreases with age. A team from Technical University Munich has published an explanation in " Science " : Fat derived from myelin, which is not carried away rapidly enough by phagocytes can trigger chronic inflammation that in turn impedes regeneration. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 4, 2018 Category: International Medicine & Public Health Source Type: news

Coherence analysis of trunk and leg acceleration reveals altered postural sway strategy during standing in persons with multiple sclerosis - Huisinga J, Mancini M, Veys C, Spain R, Horak F.
Balance task performance is affected in persons with multiple sclerosis (PwMS), but the control strategies used to perform specific tasks are not well understood. The purpose of this study was to evaluate segmental control during quiet standing in PwMS and... (Source: SafetyLit)
Source: SafetyLit - December 29, 2017 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news